134 related articles for article (PubMed ID: 28253176)
1. Intranasal tetracaine and oxymetazoline spray for maxillary local anesthesia without injections.
Saraghi M; Hersh EV
Gen Dent; 2017; 65(2):16-19. PubMed ID: 28253176
[No Abstract] [Full Text] [Related]
2. Anesthetic Efficacy of Intranasal 3% Tetracaine plus 0.05% Oxymetazoline (Kovanaze) in Maxillary Teeth.
Capetillo J; Drum M; Reader A; Fowler S; Nusstein J; Beck M
J Endod; 2019 Mar; 45(3):257-262. PubMed ID: 30803532
[TBL] [Abstract][Full Text] [Related]
3. Double-masked, randomized, placebo-controlled study to evaluate the efficacy and tolerability of intranasal K305 (3% tetracaine plus 0.05% oxymetazoline) in anesthetizing maxillary teeth.
Hersh EV; Pinto A; Saraghi M; Saleh N; Pulaski L; Gordon SM; Barnes D; Kaplowitz G; Bloom I; Sabti M; Moore PA; Lee S; Meharry M; He DY; Li Y
J Am Dent Assoc; 2016 Apr; 147(4):278-87. PubMed ID: 26822100
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of a novel nasal spray for maxillary dental anesthesia.
Ciancio SG; Hutcheson MC; Ayoub F; Pantera EA; Pantera CT; Garlapo DA; Sobieraj BD; Almubarak SA
J Dent Res; 2013 Jul; 92(7 Suppl):43S-8S. PubMed ID: 23690356
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 3 intranasal mists for anesthetizing maxillary teeth in adults: A randomized, double-masked, multicenter phase 3 clinical trial.
Ciancio SG; Marberger AD; Ayoub F; Garlapo DA; Pantera EA; Pantera CT; Al-Mubarak S; Sobieraj BD; He DY; Myneni SR
J Am Dent Assoc; 2016 May; 147(5):339-347.e1. PubMed ID: 26892312
[TBL] [Abstract][Full Text] [Related]
6. The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findings.
Giannakopoulos H; Levin LM; Chou JC; Cacek AT; Hutcheson M; Secreto SA; Moore PA; Hersh EV
J Am Dent Assoc; 2012 Aug; 143(8):872-80. PubMed ID: 22855901
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics of an Intranasally Administered Combination of Oxymetazoline and Tetracaine in Healthy Volunteers.
Cacek AT; Gobburu JV; Gopalakrishnan M
J Clin Pharmacol; 2017 Feb; 57(2):247-254. PubMed ID: 27436060
[TBL] [Abstract][Full Text] [Related]
8. Intranasal tetracaine and oxymetazoline: a newly approved drug formulation that provides maxillary dental anesthesia without needles.
Hersh EV; Saraghi M; Moore PA
Curr Med Res Opin; 2016 Nov; 32(11):1919-1925. PubMed ID: 27646144
[TBL] [Abstract][Full Text] [Related]
9. Intranasal 3% Tetracaine Plus 0.05% Oxymetazoline in the Management of Status Migrainosus.
Darsey M; Kyros T; Wang V; Rizzoli PB
Headache; 2020 Feb; 60(2):471-472. PubMed ID: 31919839
[No Abstract] [Full Text] [Related]
10. Intranasal anesthetic effects of lidocaine and tetracaine compared.
Noorily AD; Otto RA; Noorily SH
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):370-4. PubMed ID: 7567006
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis.
Ackerhans M; Jannert M; Tönnesson M
Acta Otolaryngol Suppl; 1994; 515():49-52. PubMed ID: 8067244
[TBL] [Abstract][Full Text] [Related]
12. Clinical anatomy of regional analgesia: an approach to failure.
Heasman PA; Beynon AD
Dent Update; 1986; 13(10):469, 471-4, 476. PubMed ID: 3470225
[No Abstract] [Full Text] [Related]
13. [Alveolar anesthesia].
Alantar SA; Legens M; Roche Y; Carpentier P
Actual Odontostomatol (Paris); 1989 Jun; 42(166):335-47. PubMed ID: 2635558
[TBL] [Abstract][Full Text] [Related]
14. The AMSA block: local anesthesia without collateral numbness.
Gomolka KA
CDS Rev; 2000 Oct; 93(7):34. PubMed ID: 11276886
[No Abstract] [Full Text] [Related]
15. [Block anesthesia of the superior maxillary nerve via transpalatine route].
Saborido Taboadad G
Bol Inf Dent (Madr); 1977; 37(287):37-47. PubMed ID: 270350
[No Abstract] [Full Text] [Related]
16. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging.
Pritchard S; Glover M; Guthrie G; Brum J; Ramsey D; Kappler G; Thomas P; Stuart S; Hull D; Gowland P
Pulm Pharmacol Ther; 2014 Feb; 27(1):121-6. PubMed ID: 23988443
[TBL] [Abstract][Full Text] [Related]
17. Acute coronary syndrome after nasal spray of oxymetazoline.
Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
[No Abstract] [Full Text] [Related]
18. Anesthetizing the anterior palatine nerve through the maxillary tuberosity.
Li Q
Quintessence Int; 1989 Dec; 20(12):925. PubMed ID: 2639408
[No Abstract] [Full Text] [Related]
19. [Local and regional anesthesia in dentistry. 2].
Carpentier P; Sandot T; Machtou P; Ouhayoun JP
Rev Odontostomatol (Paris); 1982; 11(1):9-25. PubMed ID: 6953549
[No Abstract] [Full Text] [Related]
20. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
